Nucleotide excision repair from site-specifically platinum-modified nucleosomes

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• Nucleotide excision repair (NER) is crucial for cellular defense against DNA damage caused by platinum-based chemotherapy drugs like cisplatin.
• Platinum-DNA adducts, particularly intrastrand cross-links, pose significant challenges to DNA repair mechanisms within the complex chromatin environment.

Purpose of the Study:

• To investigate how nucleosomes, the basic units of chromatin, affect the repair of specific platinum-DNA adducts via NER.
• To explore the role of histone post-translational modifications in modulating the efficiency of NER on damaged nucleosomal DNA.

Main Methods:

• Preparation of mononucleosomes containing site-specific platinum-DNA adducts (d(GpG)-Pt and d(GpTpG)-Pt).
• In vitro repair assays using mammalian cell extracts to compare NER efficiency on free DNA versus nucleosomal DNA.
• Comparison of repair rates between native and recombinant nucleosomes to assess the impact of histone modifications.

Main Results:

• Nucleosomes significantly inhibit NER of platinum-DNA adducts, reducing repair to 10-30% of levels seen with free DNA.
• Excision repair from native nucleosomal DNA was approximately twofold higher than from recombinant nucleosomes, indicating a role for histone modifications.
• This study establishes an in vitro system to study NER of platinum-DNA adducts in chromatin.

Conclusions:

• The nucleosome structure poses a barrier to efficient nucleotide excision repair of platinum-DNA adducts.
• Post-translational modifications of histones play a critical role in modulating NER efficiency within chromatin.
• Understanding these mechanisms is vital for optimizing platinum-based cancer therapies and predicting patient responses.